Page 200 - Genomic Medicine in Emerging Economies
P. 200

Index









           A                             C                                herbal formula of San Huang Xie
                                                                            Xin Tang (SHXXT), 58
           Acupuncture, 59               Capacity building, 186           suboptimal health status
           ADHD. See Attention-deficit/  Career development session,        (SHS), 60
                hyperactivity disorder        in summer school, 181      urban health care system, 58
                (ADHD)                   BBB-Catenin, 37               Chinese-international genomics
           Alcohol dependence, 72        CEA. See Cost-effectiveness analysis   collaboration, 27
           Allopurinol, 141                   (CEA)                    Chromatin, 102
           Alzheimer's disease, 72       Center for Disease Control    Chromosomes, 102
           Anticipated cost-efficacy          and Prevention           Clinical benefits, 13
                outcomes, 133                 (CDC), 51                Clinical care, 13
           Anticoagulation therapy, 134–138  Cervical cancer (CC) screening   Clinical genomic capabilities, 14
           Antidepressants, 139               program, 135, 136        Colombia, 50
           Anxiety disorders, 72         China, 27                       BRAF/KRAS/EGFR mutation rate,
           APC gene mutations, in Latin    acupuncture practice, genomics   168
                American studies, 88          theory to support, 39      cancer-related mortality, 65
           Argentina's universities, 105   current state of public       clinical genetics and genetic
           Arrhythmia, 101                    health, 27                    counseling, 161
           Asia Pacific Society of Human Genetics   demographics and family   deep impact on economic, social,
                Meeting, Hanoi, 2015, 14      planning, 55                  and cultural development, 160
           Attention-deficit/hyperactivity   genetics education, 34, 56  environmental cancer risk in
                disorder (ADHD), 79        genetic testing, 33              patients, 170
           Attitudes, 14, 20               genomics-related public health   founder mutation
           Automation, 108                    programs and services, 62   in genes BRCA1 and BRCA2, 54
           Autosomal dominant polycistic   growing international          in PSEN1 gene, 161
                kidney disease, 114           participation, 27          genetic composition of
           Awareness, on genomic medicine,   herb–drug interactions, application   population, 161
                159, 186                      of genomic medicine,       genetics laws and regulations, 163
             CME-accredited, 176              39–60                      health care system in, 161
             concept of, 177               newborn screening, 32          parties, 162
             Golden Helix conferences, 177, 179  prenatal screening, 66  international collaborations to
              locations worldwide, 176     projects related with human      advance medical genomics,
              logos of, 163                   genome, 34                    166
             self-declared, lack of appropriate   public health care structure, 58  migration history and admixture, 52
                genomics education, 175    rural health care system, 60  molecular/genetic diagnostic
                                           Traditional Chinese Medicine, 27
                                                                            laboratories, 164
           B                                elucidation of putative      Oncogenetics Unit in the Instituto
           Biodiversity, 27                   biological mechanisms by      De Cancerología Las
           Bioinformatics, 14                 genomic approaches, 37        Américas, 165
             capacity, 27                   and genomics, concepts of, 34  oncogenetics unit model, 63
           Bipolar disorder (BP), 72        genomics technologies in     orphan diseasesin Colombian
           BRCA1/2 mutation, 29, 30, 153      authentication, application   legislation, 167
             screening, 73                    of, 36                     to overcome obstacles, 50   189
   195   196   197   198   199   200   201   202   203   204   205